Cite
18F-FPRGD2 PET/CT Imaging of Integrin αvβ3 in Renal Carcinomas: Correlation with Histopathology
MLA
David Waltregny, et al. “18F-FPRGD2 PET/CT Imaging of Integrin Αvβ3 in Renal Carcinomas: Correlation with Histopathology.” Journal of Nuclear Medicine, vol. 56, Feb. 2015, pp. 361–64. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8040d67d8540541c6b253316ebc2c2d1&authtype=sso&custid=ns315887.
APA
David Waltregny, Nadia Withofs, Roland Hustinx, Nicolas Signolle, Pierre Lovinfosse, Fabrice Giacomelli, Didier Cataldo, Sanjiv S. Gambhir, Eugène Mutijima Nzaramba, Joan Somja, & Frédéric Mievis. (2015). 18F-FPRGD2 PET/CT Imaging of Integrin αvβ3 in Renal Carcinomas: Correlation with Histopathology. Journal of Nuclear Medicine, 56, 361–364.
Chicago
David Waltregny, Nadia Withofs, Roland Hustinx, Nicolas Signolle, Pierre Lovinfosse, Fabrice Giacomelli, Didier Cataldo, et al. 2015. “18F-FPRGD2 PET/CT Imaging of Integrin Αvβ3 in Renal Carcinomas: Correlation with Histopathology.” Journal of Nuclear Medicine 56 (February): 361–64. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8040d67d8540541c6b253316ebc2c2d1&authtype=sso&custid=ns315887.